BTG Logo (WIPO, 31.03.2016)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke BTG wurde als Bildmarke am 31.03.2016 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Kreise #Linien, Bänder #Kreise mit anderen figurativen Elementen #Kreise mit dunklen Flächen oder Teilen von Flächen #Schräge Linien oder Bänder
| Markenform | Bildmarke |
| Aktenzeichen | 1308581 |
| Länder | 
|
| Basismarke |
Nr. UK00003157313,
31. März 2016
|
| Anmeldedatum | 31. März 2016 |
| Ablaufdatum | 31. März 2026 |
Markeninhaber
100 New Bridge Street
London EC4V 6JA
GB
London EC4V 6JA
GB
Markenvertreter
Seventh Floor Offices
Artillery House
GB
Waren und Dienstleistungen
05
Pharmaceutical and medicinal preparations and substances;
veterinary preparations and substances; sanitary
preparations for medical purposes; dietetic substances
adapted for medical use, vaccines; sera; diagnostic reagents
and substances, all for in vivo use; antibodies, therapeutic
antibodies for use as anti-lymphocytic agents;
pharmaceutical preparations in the form of foams or for use
in producing foams; pharmaceutical preparations in the form
of foams or for use in producing foams, for sclerotherapy,
phlebology, angiology or proctology, for treatment of
oesophageal varices, hydroceles, in sterilisation treatment
or for treatment of varicose veins, or arterio-venous
malformations; chemical reagents for medical or veterinary
purposes; chemical reagents for therapeutic and diagnostic
purposes; chemico-pharmaceutical preparations; chemical
preparations for medical or pharmaceutical purposes;
pharmaceutical preparations for the treatment of cancer;
pharmaceutical and veterinary preparations for the reduction
or elimination of circulating cytokines; pharmaceutical and
veterinary preparations for the treatment of digoxin,
digitalis or other cardio-active glycoside toxicity;
pharmaceutical and veterinary preparations for treatment of
envenomation by snakes; pharmaceutical and veterinary
preparations for the treatment of hypertension;
pharmaceutical preparations for the treatment of migraine;
pharmaceutical preparations for the treatment of multiple
neurodegeneration and multiple sclerosis; pharmaceutical
preparations for the treatment of Alzheimer's disease;
pharmaceutical preparations for the treatment of
methotrexate toxicity; pharmaceutical preparations for the
treatment of immune disorders including type 1 diabetes,
psoriasis, coeliac disease and rheumatoid arthritis;
pharmaceutical preparations for the treatment of cancer
including prostate, oesophageal and brain cancer and
leukaemias; pharmaceutical preparations for the treatment of
sepsis; preparations and substances for facilitating the
delivery of pharmaceutical and medicinal preparations and
substances; pharmaceutical preparations and substances for
use in the circulatory system; pharmaceutical preparations
and substances for embolization; pharmaceutical preparations
and substances for embolization of tumours and arteriovenous
malformations (AVMs); pharmaceutical prepraations and
substances for use in the circulatory system for the
treatment of tumours and arteriovenous malformations (AVMs);
adjuvants for medicinal purposes, vaccine adjuvants and
vaccine preparations containing adjuvant; chemical reagents
for medical or veterinary purposes for the treatment of
envenomation by snakes; chemical reagents for therapeutic
and diagnostic purposes for the treatment of envenomation by
snakes; chemical preparations for medical or pharmaceutical
purposes for the treatment of envenomation by snakes;
medicines for the treatment of envenomation by snakes;
pharmaceutical and veterinary preparations for the treatment
of pre-eclampsia; chemical reagents for medical or
veterinary therapeutic and diagnostic purposes;
chemico-pharmaceutical preparations for use in the treatment
of digoxin, digitalis or other cardio-active glycoside
toxicity, and for use in the treatment of pre-eclampsia;
chemical preparations for medical or pharmaceutical purposes
and medicines for use in the treatment of digoxin, digitalis
or other cardio-active glycoside toxicity and for use in the
treatment of pre-eclampsia; transarterial chemoembolization
pharmaceutical preparations, vaccines and sera;
pharmaceutical preparations and substances for facilitating
the delivery of pharmaceutical and medicinal preparations
and substances; irradiated or radioactive microspheres used
for in vivo therapeutic medical purposes; radiotherapy
substances for medical purposes; radiopharmaceuticals;
therapeutic agents for delivery of radioactive material to
target sites within the body; beads, including microscopic
radioactive beads, for treatment of cancerous tumours;
beads, including microscopic glass beads, impregnated with
radioactive material for treatment of cancerous tumours;
beads, radioactive glass beads for medical purposes;
pharmaceutical preparations for use with ultrasound waves to
enhance drug delivery and/or medically activate drugs;
pharmaceutical preparations in the form of foams for use in
sclerotherapy treatment of veins; pharmaceutical
preparations in the form of foams for use in producing foams
for use in sclerotherapy treatment of veins; pharmaceutical
preparations in the form of foams or for use in producing
foams for sclerotherapy, phlebology, angiology and
proctology, for treatment of oesophageal varices,
hydroceles, in sterilisation treatment or for treatment of
varicose veins, or arterio-venous malformations;
pharmaceutical preparations containing methotrexate
antidotes; pharmaceutical preparations containing
5-fluorouracil antidotes; pharmaceutical preparations for
use in chemotherapy and autoimmune diseases; pharmaceutical
preparations used for regulating toxicity levels of
therapeutic agents; pharmaceutical preparations used for
depleting concentrations of therapeutic agents
09
Scientific, measuring, checking (supervision), teaching
apparatus and instruments; magnetic data carriers, data
carriers, databases, recording discs; data in
machine-readable form; electronically, optically or
magnetically recorded data; recorded films, tapes, compact
discs, laser discs, CD-ROM's, DVDs and other digital
recording media and cassettes bearing sound and/or images;
data processing equipment, computers; apparatus and
instruments for receiving, collecting, capturing, acquiring,
collating, recording, transmitting, storing, analysing,
processing, developing, converting, accessing, handling,
displaying, encoding, logging, relaying, communicating,
inputting, outputting and/or reproducing data, sound and/or
images; computer installations, apparatus and instruments;
computer imaging systems; imaging apparatus; apparatus,
peripheral apparatus, components and instruments for use
with computers; computer firmware; computer hardware;
computer peripherals; computer software and computer
programmes; computer software for use in medical devices;
computer software for use in ultrasound devices; computer
software for use in the medical and/or pharmaceutical
fields; computer software and computer programmes providing
information to medical professionals and patients; computer
software and telecommunications apparatus (including modems)
to enable connection to databases and the internet; computer
software to enable searching for data; computer programs for
use in the field of health care for the collection,
maintenance and management of data for patient records,
clinical diagnosis and assessment, patient treatment, goals
management, outcome analysis, scheduling, health care
facilities management, materials management, resources
utilization, billing and accounting, and the review of
health care facilities, services and clinical records;
computer software for use by health care providers to
analyse the outcomes of medical procedures and information
relating to patient care; computer software for use in
database management; computer databases for clinical use,
clinical governance, clinical audit, collecting and
analysing information relating to patient demographics,
procedures and outcomes; computer software and computer
displays for use in relation to medical purposes; computer
hardware, computer software and computer programs in the
field of ultrasound technology; apparatus for generating and
transmitting ultrasound; electric and electronic control
systems for controlling medical apparatus and instruments;
electric and electronic control systems for controlling
apparatus for generating and transmitting ultrasound; data
processing apparatus and computers for controlling medical
apparatus and instruments; data processing apparatus and
computers for controlling apparatus for generating and
transmitting ultrasound; computer software for controlling
medical apparatus and instruments; computer software for
controlling apparatus for generating and transmitting
ultrasound; stands for computer equipment; medical software
for processing and displaying images on ultrasound medical
imaging apparatus; medical imaging software that records,
monitors and analyses data using an ultrasound imaging
probe; medical workstation comprised of computer hardware
and software for gathering and transmitting patient image
data for use during surgical procedures; software for
processing digital images of the anatomy for diagnosis and
treatment; software for medical imaging; equipment for
scientific research and for diagnosis, including ultrasound
imaging systems comprising ultrasound scanners, ultrasound
imaging devices, and ancillary equipment; computer software
for use in relation to ultrasound imaging and scanning;
imaging units; electronic apparatus and instruments for use
in relation to ultrasound imaging and scanning; downloadable
electronic questionnaires; downloadable electronic patient
reported outcome questionnaires; downloadable electronic
patient reported outcome questionnaires for use with a
telecommunications device; downloadable publications in
electronic form; downloadable electronic publications
provided on-line from databases or the internet; computer
software and downloadable publications in electronic form
supplied on-line from databases or from facilities provided
on the internet (including websites); optical detection,
inspection, measuring and testing apparatus and instruments;
optical viewing and recording apparatus; electrically
operated diagnostic testing apparatus and instruments;
spectrophotometers; ultrasonic diagnostic apparatus; parts
and fittings for all the aforesaid goods
10
Surgical, medical, dental and veterinary apparatus and
instruments; artificial limbs, orthopaedic articles;
syringes, cannula needles, medical tubing; surgical and
medical apparatus for producing and administering foams;
surgical and medical apparatus for producing and
administering sclerosing foams; surgical or medical
apparatus for or for producing foams for use in
sclerotherapy, phlebology, angiology or proctology,
sterilisation treatment or for treatment of varicose veins,
arterio-venous malformations, oesophageal varices or
hydroceles; surgical and medical devices for assessing the
physical characteristics of such foams, devices for
intravenous administration of foam and devices for
monitoring the position and effect of foam in the human
body; diagnostic devices for use in all the above medical
conditions; haemofiltration devices; drug delivery
embolisation apparatus, instruments and systems; apparatus
and instruments for use in the circulatory system; apparatus
and instruments for embolisation; surgical and medical
apparatus and instruments, namely, catheters, injection
syringes and sealed vial devices for dispensing microspheres
during embolisation procedures in blood vessels and in the
circulatory system; embolisation apparatus, instruments and
systems comprising surgical and medical instruments for
embolisation; drug delivery embolisation systems; drug
delivery apparatus and instruments comprised of injection
syringes, and sealed vials; injection syringes for use with
catheters; apparatus and instruments for use in the
circulatory system, namely, catheters, injection syringes
and sealed vials; medical apparatus and instruments for
embolisation; surgical and medical apparatus and instruments
for embolisation, namely, embolisation apparatus,
instruments and systems comprising microspheres and
injection syringes for use in blood vessels and the
circulatory system to carry out embolisation; radiotherapy
apparatus; surgical and medical apparatus and instruments
for delivery of radiopharmaceuticals and radioactive
material to target sites within the body; beads, including
microscopic glass beads, impregnated with radioactive
material or containing radioactive material and administered
surgically for treatment of cancerous tumours; radioactive
beads, including radioactive glass beads administered for
treatment of cancerous tumours; surgical and medical
apparatus and instruments for use in the circulatory system;
medical devices which use ultrasound to enhance drug
delivery and/or medically activate drugs; catheters for
delivery of drugs or fluids and controllers and power units
for infusion catheters; ultrasonic drug delivery and drug
activation apparatus and controllers and power units
therefor; needles for medical use, namely, cannula needles;
medical tubing for sclerotherapy; medical tubing for the
treatment of varicose veins, venous malformations,
arterio-venous malformations, oesophageal varices and
hydroceles; surgical and medical apparatus for producing and
administering foams for the treatment of varicose veins,
venous malformations, arterio-venous malformations,
oesophageal varices and hydroceles; surgical and medical
apparatus for producing and administering sclerosing foams
for the treatment of varicose veins, venous malformations,
arterio-venous malformations, oesophageal varices and
hydroceles; syringes for producing and administering foams
for use in sclerotherapy, phlebology, angiology or
proctology; surgical and medical apparatus for administering
and producing foams for use in sterilisation treatment;
surgical and medical apparatus for use in treatment of
varicose veins, arterio-venous malformations, oesophageal
varices or hycroceles; syringes for use in treatment of
varicose veins, arterio-venous malformations, oesophageal
varices or hydroceles; surgical and medical devices for
assessing the physical characteristics of such foams;
medical devices for intravenous administration of sclerosing
foam for the treatment of varicose veins, venous
malformations, arterio-venous malformations, oesophageal
varices and hydroceles; medical devices for monitoring the
position and effect of foam in the human body; medical
diagnostic apparatus for diagnosing all the above medical
conditions; compression bandages; surgical, medical and
diagnostic materials, devices, apparatus and instruments for
use in interventional pulmonology; medical devices for use
in pulmonary and thoracic surgery and procedures; lung
volume reduction devices; artificial surgical implants for
use in interventional pulmonology; surgical implants
comprising artificial surgical implants for restoring,
maintaining and improving patient breathing, and artificial
surgical implants for restoring, maintaining and improving
lung function; parts and fittings for all of the aforesaid
goods
41
Education; provision of educational content; provision of
educational content for apps (applications) for mobile
devices and computers; providing education information in
the fields of healthcare, pharmaceuticals, medical devices,
medical research, surgery, medical science and medicine and
patient care by means of computer, electronic and online
databases; provision of education and training in the fields
of healthcare, pharmaceuticals, medical devices, medical
research, surgery, medical science and medicine and patient
care; provision of education and training in the field of
health and medical information and related hotline services;
arranging, and conducting educational conferences and
programs and providing courses of instruction in the fields
of healthcare, pharmaceuticals, medical devices, medical
research, surgery, medical science and medicine and patient
care; provision and publication of educational material and
content in the fields of healthcare, pharmaceuticals,
medical devices, medical research, surgery, medical science
and medicine and patient care; conducting educational
seminars in the fields healthcare, pharmaceuticals, medical
devices, medical research, surgery, medical science and
medicine and patient care and distribution of course
materials therewith; information and advice relating to
education, training and development provided online from a
computer database or the internet, all relating to
healthcare, pharmaceuticals, medical devices, medical
research, surgery, medical science and medicine and patient
care; providing teaching guides, instructional materials,
brochures including non-downloadable electronic
publications; providing educational electronic online
databases for healthcare, pharmaceuticals, medical devices,
medical research, surgery, medical science and medicine and
patient care
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 22. August 2022 | 2022/36 Gaz | MX | RAW: Refusal Transfer of Ownership |
| 17. November 2021 | 2021/48 Gaz | CN | RAW: Refusal Transfer of Ownership |
| 27. Juli 2020 | 2020/32 Gaz | IL | Ablehnung |
| 17. April 2020 | 2020/17 Gaz | CN | RAW: Rule 18ter(4) all goods and services protected |
| 22. August 2019 | 2019/38 Gaz | NZ | Ablehnung |
| 30. Juli 2019 | 2019/31 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 28. Februar 2019 | 2019/10 Gaz | TR | Ablehnung |
| 12. Februar 2019 | 2019/27 Gaz | SM | Ablehnung |
| 24. Januar 2019 | 2019/6 Gaz | CO | Ablehnung |
| 11. Januar 2019 | 2019/8 Gaz | RS | Ablehnung |
| 10. Januar 2019 | 2019/3 Gaz | KR | Ablehnung |
| 27. Dezember 2018 | 2019/2 Gaz | IL | Ablehnung |
| 07. September 2018 | 2018/41 Gaz | NZ | Ablehnung |
| 07. August 2018 | 2018/39 Gaz | TR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 02. Juli 2018 | 2018/42 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 06. März 2018 | Korrektur | ||
| 26. Januar 2018 | 2018/5 Gaz | KR | Ablehnung |
| 25. Januar 2018 | 2018/4 Gaz | MX | Ablehnung |
| 18. Januar 2018 | 2018/4 Gaz | TR | Ablehnung |
| 28. Dezember 2017 | 2018/4 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 27. Dezember 2017 | 2018/3 Gaz | CN | Ablehnung |
| 28. November 2017 | 2017/50 Gaz | TR | Ablehnung |
| 21. November 2017 | 2017/48 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 04. August 2017 | Korrektur | ||
| 31. Juli 2017 | 2017/31 Gaz | CH | Ablehnung |
| 22. Juli 2017 | 2017/42 Gaz | VN | Ablehnung |
| 12. Juni 2017 | 2017/27 Gaz | IN | Ablehnung |
| 02. Juni 2017 | 2017/22 Gaz | NO | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 19. Mai 2017 | 2017/32 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 19. Mai 2017 | 2017/25 Gaz | RU | Ablehnung |
| 23. März 2017 | 2017/23 Gaz | IS | Ablehnung |
| 09. März 2017 | 2017/12 Gaz | JP | Ablehnung |
| 22. Februar 2017 | 2017/8 Gaz | EM | Ablehnung |
| 13. Februar 2017 | 2017/8 Gaz | KR | Ablehnung |
| 20. Dezember 2016 | GB | RAW: Partial Ceasing Effect | |
| 15. Dezember 2016 | 2016/51 Gaz | PH | Ablehnung |
| 11. Dezember 2016 | 2017/5 Gaz | TR | Ablehnung |
| 01. Dezember 2016 | 2017/2 Gaz | NO | Ablehnung |
| 10. November 2016 | 2016/48 Gaz | SG | Ablehnung |
| 20. Oktober 2016 | 2016/43 Gaz | AU | Ablehnung |
| 31. März 2016 | GB | Eintragung |
ID: 141308581